LEAP THERAPEUTICS, INC. Annual Operating Income (Loss) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Leap Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
  • Leap Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$17.9M, a 20.4% decline year-over-year.
  • Leap Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$68.8M, a 20.2% increase year-over-year.
  • Leap Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$87M, a 53.3% decline from 2022.
  • Leap Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$56.8M, a 37% decline from 2021.
  • Leap Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$41.4M, a 45.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$87M -$30.3M -53.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 -$56.8M -$15.3M -37% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 -$41.4M -$12.9M -45.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 -$28.5M +$4.91M +14.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 -$33.5M -$2.7M -8.78% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 -$30.8M +$1.6M +4.95% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 -$32.4M -$5.05M -18.5% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 -$27.3M Jan 1, 2016 Dec 31, 2016 10-K 2018-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.